Samuel K. So

Asian Liver Center, Stanford University School of Medicine

Affiliated withStanford University School of Medicine

Research Area

Biography

Samuel K. So has not added Biography.
If you are Samuel K. So and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 11	2022

Other Publications

Article	Year
Major hepatic resection without blood transfusion: experience with total vascular exclusion. Journal of gastroenterology and hepatology\| PubMed ID: 10382635	1999
Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis? Journal of gastroenterology and hepatology\| PubMed ID: 10382639	1999
Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Techniques in vascular and interventional radiology\| PubMed ID: 12524643	2002
Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. Anticancer research\| PubMed ID: 16827101	2006
The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer\| PubMed ID: 17385214	2007
Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Annals of internal medicine\| PubMed ID: 17909207	2007
The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans. Journal of immigrant and minority health\| PubMed ID: 17990118	2009
Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. Molecular cancer\| PubMed ID: 18269767	2008
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Molecular cancer\| PubMed ID: 19778454	2009
Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology (Baltimore, Md.)\| PubMed ID: 19839061	2010
Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 20940276	2010
San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer. Journal of community health\| PubMed ID: 21125320	2011
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Molecular cancer\| PubMed ID: 21314951	2011
Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions. Interfaces\| PubMed ID: 21760650	2011
Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2. Neoplasia (New York, N.Y.)\| PubMed ID: 21847365	2011
Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes. BioMed research international\| PubMed ID: 23710458	2013
Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma. Carcinogenesis\| PubMed ID: 24302615	2014
Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer. BMC cancer\| PubMed ID: 25885205	2015
Medical training fails to prepare providers to care for patients with chronic hepatitis B infection. World journal of gastroenterology\| PubMed ID: 26078568	2015
Fatal Accelerated Cirrhosis after Imported HEV Genotype 4 Infection. Emerging infectious diseases\| PubMed ID: 26291424	2015
NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation. Oncotarget\| PubMed ID: 26359353	2015
Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling. Oncotarget\| PubMed ID: 26497681	2015
Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China. PloS one\| PubMed ID: 26536626	2015
Evaluation of the first open-access hepatitis B and safe injection online training course for health professionals in China. BMC medical education\| PubMed ID: 26952079	2016
Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention. Cancer\| PubMed ID: 30113700	2018
Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California. Hepatology, medicine and policy\| PubMed ID: 30288329	2018
An NIR-II/MR dual modal nanoprobe for liver cancer imaging. Nanoscale\| PubMed ID: 32428058	2020